Masonic Cancer Center, University of Minnesota clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 285 studies whose lead sponsor is Masonic Cancer Center, University of Minnesota. 34 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Masonic Cancer Center, University of Minnesota studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- United States
- 267
Focus areas
Conditions Masonic Cancer Center, University of Minnesota leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Leukemia60Myelodysplastic Syndromes38Leukemia, Myeloid, Acute32Lymphoma30Precursor Cell Lymphoblastic Leukemia-Lymphoma28Multiple Myeloma27Leukemia, Myelogenous, Chronic, BCR-ABL Positive18Breast Neoplasms16Leukemia, Lymphocytic, Chronic, B-Cell16Neoplasms14Ovarian Neoplasms14Fallopian Tube Neoplasms13Hematologic Neoplasms12Lung Neoplasms12Myeloproliferative Disorders10Plasmacytoma10
Studies
Recruiting first, then most recently updated. Showing 50 of 285. Browse all 285 →
- Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)RecruitingNCT07008638Phase 1/2
- Infusion of Cell Populations From Unlicensed Umbilical Cord Blood UnitsRecruitingNCT01451502Not applicable
- MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin LymphomaRecruitingNCT06377540Phase 2
- RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialRecruitingNCT04105270Phase 2
- HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZLRecruitingNCT06792825Phase 2
- Rural Smoking CessationRecruitingNCT06584929Not applicable
- Role of Acetaldehyde in the Development of Oral CancerRecruitingNCT05973656Not applicable
- HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AMLRecruitingNCT06594445Phase 1
- American Indian Smokefree Native RCTRecruitingNCT06544811Not applicable
- UNTOLD Ovarian Cancer Unmet Needs SurveyRecruitingNCT07070726
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)RecruitingNCT01666080Not applicable
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingNCT05805605Phase 2
- Myeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersRecruitingNCT03314974Phase 2
- GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal CancerNot yet recruitingNCT07661017Not applicable
- Allo HSCT for High Risk HemoglobinopathiesRecruitingNCT06872333Phase 2
- MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.RecruitingNCT06412497Phase 2
- Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCTRecruitingNCT07591649Phase 1/2
- Adrenoleukodystrophy National Registry StudyRecruitingNCT03789721
- First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 AstrocytomaRecruitingNCT07560865Phase 1
- GTB-5550 in Advanced Solid TumorsRecruitingNCT07541573Phase 1
- MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological DiseasesRecruitingNCT07493538Phase 2
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingNCT05735717Phase 2
- Observational Study of Exposure to Environmental Toxicants Among FirefightersRecruitingNCT05643014
- Trial of Cell Based Therapy for DMDRecruitingNCT06692426Phase 1
- Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor MalignanciesNot yet recruitingNCT06772090Not applicable
- Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following PancreatoduodenectomyRecruitingNCT06411795Phase 2
- Alpha/Beta TCD HCT in Patients With Inherited BMF DisordersRecruitingNCT03579875Phase 2
- Evaluation of Early Identification of Cognitive Side Effects of ImmunotherapyRecruitingNCT06414278
- Adenovirus (RGDCRAdCOX2F)RecruitingNCT06693986Phase 1
- Treatment of Graft Failure After Hematopoietic Stem Cell TransplantationRecruitingNCT02161783
- Study of PAT in Patients With Solid Tumor CancersRecruitingNCT05338658Phase 1
- Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through ExerciseRecruitingNCT05025774
- Auto Stem Cell Transplant for Lymphoma PatientsRecruitingNCT03125642Phase 2
- Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaRecruitingNCT02605421Phase 2
- Effect of Kava on Anxiety and Stress in Cancer SurvivorsWithdrawnNCT06213298Early Phase 1
- Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) UsersCompletedNCT04003805Phase 1
- Assessing the Time Demands of CancerActive, not recruitingNCT05708703
- NF-1, Nutraceutical InterventionActive, not recruitingNCT05363267Phase 1
- LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal CancerActive, not recruitingNCT07153016Not applicable
- Feasibility of Conducting a Pilot Telehealth Study Assessing the Removal of Filter Ventilation on Smoking Behavior and Biomarkers in Menthol Smokers Switched to Non-menthol CigarettesCompletedNCT04514471Not applicable
- Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer SurvivorsActive, not recruitingNCT05665543Not applicable
- Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking MeasuresActive, not recruitingNCT06295757Not applicable
- BAriaTric Surgery After Breast Cancer Treatment (BATS)WithdrawnNCT03946423Not applicable
- MT2022-01: MSCs for ALDSuspendedNCT06030648Phase 1
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesActive, not recruitingNCT01652092Not applicable
- CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneCompletedNCT03934840Phase 2
- Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological DiseasesTerminatedNCT01962636Not applicable
- Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerActive, not recruitingNCT06342986Phase 1
- Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated CorticosteroidsTerminatedNCT05123040Phase 1/2
- Sugars in CigarettesCompletedNCT05308316Not applicable